About Oncosia

Transforming cancer care.
Every patient.
Fully.

We are medical physicists and nuclear medicine physicians who worked with these patients before we built this company. We saw what was possible when dosimetry was done properly — and what was being left on the table when it wasn't. Oncosia exists to close that gap.

The team

Built by the people who know this work from the inside.

Clinicians, physicists, and regulatory specialists — united by one intent: to make a difference for the patients receiving these therapies.

Nico Schürrle
Nico Schürrle
CEO
Seval Beykan Schürrle
Dr. rer. nat. Seval Beykan Schürrle
Medical Physics
Cüneyt Türkmen
Prof. Dr. Cüneyt Türkmen
Nuclear Medicine
Jolanta Kunikoswka
Prof. Dr. Jolanta Kunikowska
Nuclear Medicine
[Name Surname]
Dr. Türkay Toklu
Medical Physics
[Name Surname]
Assoc. Prof. Bilal Kovan
Medical Physics
Gamze Ergiyen Buldu
Gamze Ergiyen Buldu
Medical Physics
[Name Surname]
Emine Özcan
Biophysics
Our history

How we got here.

Oncosia grew from clinical and research work — one step at a time, in the direction of better care for patients receiving these therapies.

2023
Origins

Curie Science Center founded

Scientific consultancy established to bridge clinical nuclear medicine and rigorous dosimetry methodology. First project portfolio, first clients.

2024
Founded

Oncosia Scientific GmbH established

Formally incorporated in Germany as a dedicated dosimetry service company, building on the clinical and scientific foundation of Curie Science Center.

Winter
2024
Research

First academic collaborations & sponsor engagements

Multiple pre-clinical and clinical dosimetry studies initiated with academic investigators. First pharmaceutical sponsors engaged for clinical programme dosimetry support.

Spring
2025
Partnership

Distributor & solution partnership with DOSIsoft

Appointed as authorised distributor and implementation partner for PLANET® Dose for Germany and Türkiye — the validated dosimetry platform for targeted radionuclide therapy.

Summer
2025
International

First PLANET® Dose installation in Türkiye

The first clinical installation of PLANET® Dose in Türkiye — delivered, configured, and validated on site by Oncosia. A milestone driven by Oncosia's direct commitment to expanding access to validated dosimetry in the region.

Winter
2025
Multisite study

¹⁶¹Tb multisite IIS launched — Oncosia as central dosimetry vendor

Launch of a multi-centre investigator-initiated study with participating centres across Europe. Oncosia serves as the central dosimetry vendor, covering full scope: site qualification, protocol implementation, centralised analysis, and reporting.

Spring
2026
Validation

First full CRO audit — passed

Formal dosimetry audit conducted by a CRO client. An independent, professional evaluation of our processes, documentation, and analytical rigour — and the strongest external validation of the service to date.